.STUDY FEATURE.06 August 2024.
A big randomized controlled trial with cisgender women highlights the challenges of faithfulness to an everyday dental preexposure treatment routine and also illustrates that twice-yearly shot of lenacapavir can keep reliable HIV prevention degrees over 6 months.